My ultimate goal is to educate other fertility specialists and laboratory professionals on the importance of PGS and its role in giving fertility patients the best chance for experiencing healthy pregnancies and live births.
Los Angeles, California (PRWEB) March 24, 2016
Experts in reproductive medicine will converge in Chicago, Illinois this month for Irvine Scientific’s “Best Practices in the IVF Lab.” Ovation Fertility™ Austin Laboratory Director Matthew (Tex) VerMilyea, PhD, HCLD/CC (ABB) will be among the esteemed speakers.
Dr. VerMilyea’s presentation focuses on the global proliferation of PGS services and the resulting need for competent IVF labs: “PGS: Preimplantation Genetic Screening or Pressure Group Success. Are you in or out?”
PGS enables fertility specialists to screen IVF embryos for chromosomal abnormalities. This type of screening is on the rise as a result of advances in cryopreservation and DNA mapping. Chromosomally abnormal embryos (aneuploid embryos) frequently cause early miscarriage in IVF cycles. PGS, however, allows IVF lab embryologists to screen for aneuploid embryos so that fertility specialists can recommend transferring only those likely to develop into healthy babies.
Ability to grow blastocyst stage embryos essential to PGS capabilities
Dr. VerMilyea plans to use his presentation to emphasize the need for IVF lab competency in PGS. He will stress that IVF labs must provide the optimal environment in which to nurture embryos to the blastocyst stage, while developing guidelines to select the best embryos for biopsy and establishing strong cryopreservation programs.
Representing Ovation Fertility™ Austin, a world leader in reproductive medicine, Dr. VerMilyea says: “My ultimate goal is to educate other fertility specialists and laboratory professionals on the importance of PGS and its role in giving fertility patients the best chance for experiencing healthy pregnancies and live births.”
The fifth annual seminar examines “current practices in andrology, biopsy and vitrification” and strives to introduce fertility specialists to “new ideas and best practices” to help improve efficiency and effectiveness in the IVF lab.
Other presentations at the Chicago seminar will focus on sperm epigenetics and embryogenesis as well as vitrification of oocytes.
About Dr. Matthew (Tex) VerMilyea
Dr. VerMilyea is the laboratory director at Ovation Fertility™ Austin and scientific director for Texas Fertility Center in Austin, Texas. In his role as scientific director, Dr. VerMilyea oversees all IVF lab procedures, and researches the latest technologies in DNA analysis, embryo development and fertility preservation. Dr. VerMilyea is a world traveler, having served as a research fellow in Japan and the United Kingdom, and as lab director for leading New Zealand fertility centers. For more information about Dr. VerMilyea, his extensive background in embryology and andrology, and his work, please visit Ovation Fertility Austin.